Successful IND Submission Paves the Way for a Global Full-Service Phase I Clinical Trial Targeting Cancers
A small-sized biotechnology company engaged Veristat early in development for help with conducting a pre-IND meeting and IND submission for a therapeutic product platform targeting cancers of the reproductive system. The sponsor initially set their sights on reaching clinical trials as swiftly as possible, but navigating the complex regulatory environment proved challenging, and the project began to run over budget and behind schedule.
Learn how Veristat helped the sponsor obtain FDA approval for its IND and move forward to reach its next development milestone.
Explore Our Key Related Services
Please fill out this form to access your resource.